Talphera (TLPH) Competitors $0.46 +0.01 (+3.10%) Closing price 07/3/2025 01:04 PM EasternExtended Trading$0.46 0.00 (0.00%) As of 07/3/2025 04:07 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock TLPH vs. EGRX, AKTX, BRNS, ELYM, ATHE, MRSN, PEPG, CLNN, LVTX, and XLOShould you be buying Talphera stock or one of its competitors? The main competitors of Talphera include Eagle Pharmaceuticals (EGRX), Akari Therapeutics (AKTX), Barinthus Biotherapeutics (BRNS), Eliem Therapeutics (ELYM), Alterity Therapeutics (ATHE), Mersana Therapeutics (MRSN), PepGen (PEPG), Clene (CLNN), LAVA Therapeutics (LVTX), and Xilio Therapeutics (XLO). These companies are all part of the "pharmaceutical products" industry. Talphera vs. Its Competitors Eagle Pharmaceuticals Akari Therapeutics Barinthus Biotherapeutics Eliem Therapeutics Alterity Therapeutics Mersana Therapeutics PepGen Clene LAVA Therapeutics Xilio Therapeutics Eagle Pharmaceuticals (NASDAQ:EGRX) and Talphera (NASDAQ:TLPH) are both small-cap medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their risk, analyst recommendations, institutional ownership, valuation, dividends, earnings, media sentiment and profitability. Do analysts recommend EGRX or TLPH? Talphera has a consensus target price of $5.00, suggesting a potential upside of 975.27%. Given Talphera's stronger consensus rating and higher possible upside, analysts plainly believe Talphera is more favorable than Eagle Pharmaceuticals.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Eagle Pharmaceuticals 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Talphera 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 2 Strong Buy rating(s) 3.50 Do insiders & institutionals have more ownership in EGRX or TLPH? 85.4% of Eagle Pharmaceuticals shares are held by institutional investors. Comparatively, 37.7% of Talphera shares are held by institutional investors. 28.9% of Eagle Pharmaceuticals shares are held by insiders. Comparatively, 3.2% of Talphera shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth. Which has more risk & volatility, EGRX or TLPH? Eagle Pharmaceuticals has a beta of 0.83, suggesting that its stock price is 17% less volatile than the S&P 500. Comparatively, Talphera has a beta of -0.11, suggesting that its stock price is 111% less volatile than the S&P 500. Does the media prefer EGRX or TLPH? In the previous week, Eagle Pharmaceuticals' average media sentiment score of 0.00 equaled Talphera'saverage media sentiment score. Company Overall Sentiment Eagle Pharmaceuticals Neutral Talphera Neutral Is EGRX or TLPH more profitable? Eagle Pharmaceuticals' return on equity of 0.00% beat Talphera's return on equity.Company Net Margins Return on Equity Return on Assets Eagle PharmaceuticalsN/A N/A N/A Talphera N/A -130.28%-59.25% Which has stronger valuation & earnings, EGRX or TLPH? Eagle Pharmaceuticals has higher revenue and earnings than Talphera. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioEagle Pharmaceuticals$257.55M0.15$35.64MN/AN/ATalphera$27K353.11-$13M-$0.45-1.03 SummaryEagle Pharmaceuticals beats Talphera on 7 of the 12 factors compared between the two stocks. Get Talphera News Delivered to You Automatically Sign up to receive the latest news and ratings for TLPH and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TLPH and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TLPH vs. The Competition Export to ExcelMetricTalpheraMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$9.25M$2.43B$5.54B$9.05BDividend YieldN/A1.78%5.24%4.02%P/E Ratio-1.038.9827.4320.22Price / Sales353.11682.84416.87118.64Price / CashN/A158.5936.8958.07Price / Book0.994.588.035.67Net Income-$13M$31.34M$3.18B$249.13M7 Day Performance-0.64%3.25%2.88%3.28%1 Month Performance-4.63%7.08%3.69%5.56%1 Year Performance-50.53%0.17%36.02%21.12% Talphera Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TLPHTalphera1.9871 of 5 stars$0.47+3.1%$5.00+975.3%-49.5%$9.25M$27K-1.0319Gap UpEGRXEagle PharmaceuticalsN/A$2.90flatN/A-45.5%$37.66M$257.55M0.00100Gap DownAKTXAkari Therapeutics1.5503 of 5 stars$1.17+0.0%N/A-62.9%$37.65MN/A0.009BRNSBarinthus Biotherapeutics2.8246 of 5 stars$0.92-0.7%$6.25+576.4%-31.8%$37.27M$14.97M-0.56107News CoverageGap UpELYMEliem TherapeuticsN/A$1.24+5.1%N/A-81.3%$36.89MN/A-2.349ATHEAlterity Therapeutics2.6533 of 5 stars$4.04-1.3%$12.00+197.4%+122.3%$35.79MN/A0.0010MRSNMersana Therapeutics3.6658 of 5 stars$0.29-3.4%$5.20+1,718.2%-84.2%$35.64M$40.50M-0.48150News CoveragePEPGPepGen2.9386 of 5 stars$1.09-2.3%$7.67+606.6%-92.7%$35.50MN/A-0.3530CLNNClene2.2987 of 5 stars$3.88-0.7%$40.00+930.7%-39.9%$35.21M$340K-0.97100News CoverageGap UpLVTXLAVA Therapeutics1.8368 of 5 stars$1.33+0.8%$3.17+138.1%-25.8%$34.99M$11.98M-1.2860Positive NewsXLOXilio Therapeutics2.7517 of 5 stars$0.68-0.6%$4.00+491.7%-19.7%$34.59M$6.34M-0.8070News Coverage Related Companies and Tools Related Companies Eagle Pharmaceuticals Alternatives Akari Therapeutics Alternatives Barinthus Biotherapeutics Alternatives Eliem Therapeutics Alternatives Alterity Therapeutics Alternatives Mersana Therapeutics Alternatives PepGen Alternatives Clene Alternatives LAVA Therapeutics Alternatives Xilio Therapeutics Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TLPH) was last updated on 7/5/2025 by MarketBeat.com Staff From Our PartnersTrump’s New Order Could Boost Social Security Benefits by 400%If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe End of Elon Musk…?The End of Elon Musk? Don't make him laugh. Jeff Brown has been hearing this same tired story for years, an...Brownstone Research | SponsoredThe $15 Gold Fund That Pays Up to $1,152/MonthGold prices are breaking records. But while everyone else is fixated on headlines… They're missing somet...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Talphera, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Talphera With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TLPH Stock Alerts